drugset / Trial / NCT00558038

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

NCT00558038

Phase 2 Completed 40 enrolled Ocera Therapeutics
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of the experimental drug AST-120 compared to lactulose in patients with mild hepatic encephalopathy.

Timeline

Start
2007-09
Primary completion
2009-03
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Activated Charcoal Other / unclassified 2 g
Comparator Lactulose Other / unclassified 30 ml